Vasacad (Valsartan)

Valsartan is a well‑established angiotensin II receptor blocker (ARB) used to manage high blood pressure, improve heart failure outcomes, and support recovery after myocardial infarction. By blocking the AT₁ receptor, valsartan relaxes blood vessels, lowers systemic vascular resistance, and reduces the workload on the heart. It is known for its strong evidence base in cardiovascular protection, particularly in heart failure with reduced ejection fraction (HFrEF), where it helps reduce hospitalizations and improve long‑term outcomes. Valsartan is also used in patients who cannot tolerate ACE inhibitors due to cough or angioedema. With once‑daily or twice‑daily dosing options and a favorable side‑effect profile, valsartan remains a widely recommended therapy in hypertension and heart‑failure guidelines.